✦ LIBER ✦
PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF Treatment
✍ Scribed by M. Ingham; L. Tang; D. Decktor; R. Bolce; J. Wang
- Book ID
- 119311182
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 71 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.